GlassScriptPhysician profile
Sharlene E Rogers
NPI 1336637354
$2,015.77
in general payments reported to CMS, 2019-2025
20 companies · $413 in 2025
The $413 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $130 · 2022: $77.32 · 2023: $809 · 2024: $585 · 2025: $413.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,808.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,807.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insulet Corporation | $295.30 | 2023-2025 | Omnipod, Omnipod |
| Amgen INC. | $207.76 | 2023-2024 | Evenity, Prolia, Repatha |
| Medtronic, INC. | $182.17 | 2021-2025 | Minimed 780g |
| Lilly USA, LLC | $166.68 | 2021-2024 | Mounjaro, Jardiance |
| Xeris Pharmaceuticals, INC. | $166.58 | 2021-2024 | Recorlev |
| Boehringer Ingelheim Pharmaceuticals, INC. | $141.80 | 2021-2024 | Jardiance |
| Neurocrine Biosciences, INC. | $139.29 | 2025 | |
| Sanofi-Aventis U.S. LLC | $133.93 | 2021-2024 | |
| Horizon Therapeutics Plc | $125.00 | 2023 | Tepezza |
| Novo Nordisk INC | $93.46 | 2022-2023 | Ozempic, Rybelsus |
| Tandem Diabetes Care, INC. | $87.63 | 2021-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Abbott Laboratories | $62.87 | 2023 | Freestyle Libre 3 |
| Dexcom, INC. | $58.32 | 2024 | Dexcom G6 Transmitter |
| Beta Bionics, INC. | $49.98 | 2024 | Ilet Bionic Pancreas |
| Otsuka America Pharmaceutical, INC. | $23.42 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amryt Pharma Holdings LTD | $18.33 | 2023 | Mycapssa |
| Fresenius USA Marketing, INC. | $17.58 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.35 | 2023 | |
| Radius Health, INC. | $15.32 | 2024 | Tymlos |
| Alexion Pharmaceuticals, INC. | $14.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sharlene Rogers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.